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IL-15 deficiency promotes tumor growth in tax
transgenic mice
Daniel Rauch, Sirosh Bokhari, John Harding, Lee Ratner*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
IL-15 is an NFkB activated cytokine with structural
similarity to IL-2 that has been implicated as a promoter
of ATLL. Proposed mechanisms include; i) establish-
ment of an autocrine loop in tumor cells that express
both IL-15 and the IL-15 receptor, ii) IL-15 mediated
protection from apoptosis, and iii) IL-15 mediated
immune regulation that promotes tumor growth. IL-15
blockade is being considered as a therapeutic approach
to HTLV-1 malignancies. To examine the effects of IL-
15 deficiency on HTLV-1 malignancy in vivo, we devel-
oped IL-15-/- TAX-LUC mice in which firefly luciferase
under the HTLV-1 LTR serves as a reporter of Tax
expression driven by the granzyme B promoter. Unex-
pectedly, the absence of IL-15 resulted in a significantly
enhanced tumor phenotype in TAX-LUC mice which
developed markedly larger, more numerous, and more
aggressive tumors. IL-15 deficiency also resulted in
severe osteolytic disease, platelet and bone marrow
abnormalities. Administration of soluble IL-15 slowed
tumor growth in vivo. Characteristics of cell lines
derived from IL-15-/- Tax tumors were indistinguishable
from tumor cells derived from IL-15+/+ Tax tumors.
RNA harvested from malignant and infiltrating cells
within tumors indicated that tumor immunity is signifi-
cantly affected by IL-15 loss. NK and gamma-delta T
cells are diminished in tumor infiltrates in the absence
of IL-15 and the malignant cells express elevated levels
of IL-1alpha. These findings reveal a profound of effect
of tumor immunity in TAX malignancies, implicate IL-
1alpha as an important factor in the immune response
to ATLL, and caution against IL-15 blockade as an
ATLL therapy.
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